Gene Symbol | Gene ID | Gene Info |
---|---|---|
Cebpe
|
ENSMUSG00000052435.6 | CCAAT/enhancer binding protein (C/EBP), epsilon |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_54736986_54737137 | Cebpe | 24887 | 0.082486 | -0.39 | 3.1e-03 | Click! |
chr14_54705827_54706225 | Cebpe | 6148 | 0.095225 | 0.30 | 2.8e-02 | Click! |
chr14_54706694_54706845 | Cebpe | 5405 | 0.098726 | 0.22 | 1.0e-01 | Click! |
chr14_54706472_54706623 | Cebpe | 5627 | 0.097572 | 0.16 | 2.4e-01 | Click! |
chr14_54742539_54742690 | Cebpe | 30440 | 0.076090 | 0.14 | 2.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 45.51 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr2_52602270_52602578 | 9.01 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
17330 |
0.2 |
chr12_8507415_8507575 | 7.72 |
5033421B08Rik |
RIKEN cDNA 5033421B08 gene |
3706 |
0.18 |
chr2_24345160_24345327 | 7.48 |
Il1rn |
interleukin 1 receptor antagonist |
45 |
0.97 |
chr1_60599018_60599192 | 7.18 |
Gm38388 |
predicted gene, 38388 |
2869 |
0.18 |
chr2_126695400_126695562 | 6.83 |
Usp8 |
ubiquitin specific peptidase 8 |
11847 |
0.13 |
chr12_79674954_79675872 | 6.57 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr3_149170299_149170505 | 6.56 |
Gm42647 |
predicted gene 42647 |
39869 |
0.16 |
chr11_110252327_110252617 | 6.54 |
Abca6 |
ATP-binding cassette, sub-family A (ABC1), member 6 |
696 |
0.77 |
chr6_28459197_28459489 | 6.47 |
Gm43264 |
predicted gene 43264 |
7638 |
0.12 |
chr16_91678624_91678810 | 6.43 |
Donson |
downstream neighbor of SON |
2593 |
0.16 |
chr9_48745121_48745413 | 6.36 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
90678 |
0.08 |
chr9_64790811_64790963 | 6.30 |
Dennd4a |
DENN/MADD domain containing 4A |
20453 |
0.18 |
chr1_88013855_88014022 | 6.22 |
Gm25198 |
predicted gene, 25198 |
1986 |
0.16 |
chr13_58006958_58007325 | 6.22 |
Mir874 |
microRNA 874 |
16059 |
0.21 |
chr4_138065957_138066120 | 6.15 |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
61286 |
0.1 |
chr2_60796909_60797719 | 6.06 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
16373 |
0.25 |
chr17_79609796_79610102 | 5.87 |
Rmdn2 |
regulator of microtubule dynamics 2 |
1914 |
0.43 |
chr19_53080891_53081464 | 5.75 |
1700054A03Rik |
RIKEN cDNA 1700054A03 gene |
400 |
0.83 |
chr2_71500010_71500161 | 5.70 |
Gm23253 |
predicted gene, 23253 |
4814 |
0.15 |
chr11_97694774_97695667 | 5.70 |
Pcgf2 |
polycomb group ring finger 2 |
2811 |
0.11 |
chr16_38433134_38433299 | 5.64 |
Pla1a |
phospholipase A1 member A |
71 |
0.96 |
chr11_55183198_55183581 | 5.48 |
Slc36a2 |
solute carrier family 36 (proton/amino acid symporter), member 2 |
1688 |
0.26 |
chr3_121531237_121531694 | 5.45 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
154 |
0.91 |
chr7_112270932_112271230 | 5.45 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
218 |
0.96 |
chr10_24948265_24948731 | 5.40 |
Gm36172 |
predicted gene, 36172 |
20879 |
0.13 |
chr2_180712270_180712735 | 5.40 |
Gid8 |
GID complex subunit 8 |
44 |
0.95 |
chr6_108836229_108836560 | 5.38 |
Edem1 |
ER degradation enhancer, mannosidase alpha-like 1 |
16 |
0.98 |
chr4_132863337_132863488 | 5.37 |
Stx12 |
syntaxin 12 |
152 |
0.93 |
chr10_94098138_94098431 | 5.29 |
Gm18391 |
predicted gene, 18391 |
144 |
0.94 |
chr18_84600609_84600911 | 5.25 |
Zfp407 |
zinc finger protein 407 |
11035 |
0.16 |
chr2_129942943_129943094 | 5.21 |
Gm28196 |
predicted gene 28196 |
5550 |
0.22 |
chr12_98375326_98375477 | 5.21 |
5330409N07Rik |
RIKEN cDNA 5330409N07 gene |
72933 |
0.08 |
chr3_144110778_144110959 | 5.20 |
Gm34078 |
predicted gene, 34078 |
24886 |
0.21 |
chr7_28824896_28825380 | 5.19 |
Ech1 |
enoyl coenzyme A hydratase 1, peroxisomal |
79 |
0.93 |
chr5_51825674_51825964 | 5.19 |
Gm43606 |
predicted gene 43606 |
32956 |
0.17 |
chr7_118935391_118935576 | 5.17 |
Iqck |
IQ motif containing K |
1640 |
0.36 |
chr2_103477493_103477777 | 5.16 |
Cat |
catalase |
7490 |
0.19 |
chr17_53650465_53650641 | 5.13 |
Kat2b |
K(lysine) acetyltransferase 2B |
5856 |
0.15 |
chr1_67116639_67117125 | 5.12 |
Cps1 |
carbamoyl-phosphate synthetase 1 |
6144 |
0.25 |
chr6_54179094_54179726 | 5.06 |
Gm15526 |
predicted gene 15526 |
1727 |
0.39 |
chr1_193543895_193544046 | 5.01 |
Mir205hg |
Mir205 host gene |
33796 |
0.14 |
chr15_38431588_38432109 | 4.98 |
G930009F23Rik |
RIKEN cDNA G930009F23 gene |
23286 |
0.13 |
chr6_117653045_117653249 | 4.98 |
Gm45083 |
predicted gene 45083 |
40577 |
0.14 |
chr1_133685767_133686128 | 4.98 |
Lax1 |
lymphocyte transmembrane adaptor 1 |
4139 |
0.15 |
chr15_67146361_67146739 | 4.96 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
17527 |
0.24 |
chr5_103963041_103963367 | 4.95 |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
14122 |
0.13 |
chr2_163643706_163643927 | 4.91 |
0610039K10Rik |
RIKEN cDNA 0610039K10 gene |
1034 |
0.35 |
chr16_94347115_94347288 | 4.87 |
Gm15310 |
predicted gene 15310 |
12111 |
0.13 |
chr7_28838319_28838669 | 4.80 |
Lgals4 |
lectin, galactose binding, soluble 4 |
2512 |
0.13 |
chr5_121591658_121591977 | 4.76 |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
1763 |
0.19 |
chr7_103859754_103859964 | 4.74 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
6643 |
0.06 |
chr19_55192593_55192828 | 4.71 |
Mir6715 |
microRNA 6715 |
32 |
0.93 |
chr2_174347204_174348264 | 4.69 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr9_71166081_71166377 | 4.68 |
Aqp9 |
aquaporin 9 |
1007 |
0.5 |
chr4_62516904_62517154 | 4.68 |
Alad |
aminolevulinate, delta-, dehydratase |
2852 |
0.16 |
chr10_20046153_20046446 | 4.68 |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
53226 |
0.13 |
chr6_41643334_41643548 | 4.68 |
Trpv6 |
transient receptor potential cation channel, subfamily V, member 6 |
7036 |
0.12 |
chr7_4739300_4740219 | 4.67 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr2_163596427_163596638 | 4.66 |
Ttpal |
tocopherol (alpha) transfer protein-like |
5782 |
0.15 |
chr1_181257261_181257857 | 4.66 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
15239 |
0.14 |
chr9_7869236_7869495 | 4.63 |
Birc3 |
baculoviral IAP repeat-containing 3 |
3492 |
0.23 |
chr15_100320593_100320744 | 4.63 |
Mettl7a3 |
methyltransferase like 7A3 |
14261 |
0.1 |
chr1_171452646_171452797 | 4.63 |
F11r |
F11 receptor |
10129 |
0.09 |
chr10_93143358_93143676 | 4.61 |
Cdk17 |
cyclin-dependent kinase 17 |
17358 |
0.17 |
chr7_109191268_109192295 | 4.60 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr5_99284500_99284682 | 4.59 |
Gm35394 |
predicted gene, 35394 |
10496 |
0.23 |
chr15_57889516_57889687 | 4.55 |
Derl1 |
Der1-like domain family, member 1 |
793 |
0.66 |
chr7_80542454_80542814 | 4.51 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr15_7931542_7931873 | 4.49 |
Rpl19-ps6 |
ribosomal protein L19, pseudogene 6 |
43368 |
0.13 |
chr12_78206300_78206505 | 4.48 |
Gm6657 |
predicted gene 6657 |
5436 |
0.17 |
chr17_57228051_57228489 | 4.47 |
C3 |
complement component 3 |
134 |
0.93 |
chr5_96921082_96921373 | 4.46 |
Gm8013 |
predicted gene 8013 |
45 |
0.93 |
chr2_75716191_75716375 | 4.45 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
11513 |
0.12 |
chr19_53781358_53781549 | 4.45 |
Rbm20 |
RNA binding motif protein 20 |
11855 |
0.17 |
chr10_117301874_117302025 | 4.44 |
Lyz1 |
lysozyme 1 |
9081 |
0.14 |
chr7_45992565_45992723 | 4.43 |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
8425 |
0.11 |
chr14_20135067_20135239 | 4.41 |
Saysd1 |
SAYSVFN motif domain containing 1 |
3381 |
0.2 |
chr15_78840308_78840489 | 4.40 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
2226 |
0.15 |
chr3_131017962_131018270 | 4.40 |
A430072C10Rik |
RIKEN cDNA A430072C10 gene |
8254 |
0.19 |
chr19_44021600_44021916 | 4.38 |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
7441 |
0.15 |
chr5_89278221_89278372 | 4.36 |
Gc |
vitamin D binding protein |
157332 |
0.04 |
chr3_52600555_52600836 | 4.35 |
Gm10293 |
predicted pseudogene 10293 |
12140 |
0.24 |
chr2_70922937_70923095 | 4.35 |
Gm13632 |
predicted gene 13632 |
45187 |
0.13 |
chr4_63344319_63344624 | 4.34 |
Orm1 |
orosomucoid 1 |
89 |
0.95 |
chr7_80400149_80400443 | 4.33 |
Furin |
furin (paired basic amino acid cleaving enzyme) |
827 |
0.44 |
chr6_3265625_3265784 | 4.30 |
Gm42961 |
predicted gene 42961 |
11849 |
0.12 |
chr13_52822783_52823147 | 4.28 |
BB123696 |
expressed sequence BB123696 |
65760 |
0.12 |
chr12_15653337_15653804 | 4.27 |
Gm4804 |
predicted gene 4804 |
47158 |
0.15 |
chr7_118699015_118699188 | 4.27 |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
6279 |
0.13 |
chr3_118478077_118478363 | 4.27 |
Gm26871 |
predicted gene, 26871 |
20561 |
0.14 |
chr14_26097723_26097874 | 4.26 |
Cphx2 |
cytoplasmic polyadenylated homeobox 2 |
6237 |
0.12 |
chr14_26237336_26237487 | 4.26 |
Cphx3 |
cytoplasmic polyadenylated homeobox 3 |
6239 |
0.13 |
chr6_142614297_142614735 | 4.26 |
5330439B14Rik |
RIKEN cDNA 5330439B14 gene |
79 |
0.98 |
chr16_95728896_95729375 | 4.25 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
11401 |
0.18 |
chr7_84201700_84201889 | 4.24 |
Gm44826 |
predicted gene 44826 |
8720 |
0.15 |
chr2_35063425_35063648 | 4.24 |
Hc |
hemolytic complement |
2098 |
0.27 |
chr7_44683455_44684071 | 4.24 |
2310016G11Rik |
RIKEN cDNA 2310016G11 gene |
6909 |
0.1 |
chr15_3251016_3251325 | 4.21 |
Selenop |
selenoprotein P |
17377 |
0.19 |
chr17_63312450_63312612 | 4.21 |
4930405O22Rik |
RIKEN cDNA 4930405O22 gene |
440 |
0.85 |
chr14_25957965_25958116 | 4.20 |
Cphx1 |
cytoplasmic polyadenylated homeobox 1 |
3372 |
0.15 |
chr18_69946685_69946957 | 4.19 |
Ccdc68 |
coiled-coil domain containing 68 |
21245 |
0.15 |
chr2_3664223_3664517 | 4.19 |
Gm13183 |
predicted gene 13183 |
16220 |
0.16 |
chr9_74326082_74326245 | 4.18 |
Gm24141 |
predicted gene, 24141 |
36447 |
0.16 |
chr16_24517632_24517783 | 4.17 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
11687 |
0.25 |
chr1_21240291_21240609 | 4.17 |
Gsta3 |
glutathione S-transferase, alpha 3 |
139 |
0.93 |
chr19_28960821_28961003 | 4.16 |
4430402I18Rik |
RIKEN cDNA 4430402I18 gene |
2675 |
0.17 |
chr16_93189552_93189703 | 4.15 |
Gm28003 |
predicted gene, 28003 |
116872 |
0.06 |
chr18_46604413_46604564 | 4.14 |
Eif1a |
eukaryotic translation initiation factor 1A |
6474 |
0.14 |
chr8_26024377_26024528 | 4.13 |
Gm45411 |
predicted gene 45411 |
1042 |
0.38 |
chr14_59880775_59881099 | 4.13 |
Gm9013 |
predicted gene 9013 |
159554 |
0.03 |
chr3_7630990_7631141 | 4.12 |
Il7 |
interleukin 7 |
17305 |
0.2 |
chr11_5502424_5502575 | 4.12 |
Gm11963 |
predicted gene 11963 |
3659 |
0.16 |
chr4_53108006_53108592 | 4.12 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
51596 |
0.12 |
chr17_31901504_31901717 | 4.11 |
Gm50000 |
predicted gene, 50000 |
2432 |
0.21 |
chr2_5563768_5563948 | 4.11 |
Gm13216 |
predicted gene 13216 |
39713 |
0.19 |
chr9_46215286_46215938 | 4.09 |
Sik3 |
SIK family kinase 3 |
3959 |
0.12 |
chr16_72734272_72734567 | 4.09 |
Robo1 |
roundabout guidance receptor 1 |
71215 |
0.14 |
chr4_141187543_141187829 | 4.08 |
Cplane2 |
ciliogenesis and planar polarity effector 2 |
26270 |
0.1 |
chr13_92651097_92651373 | 4.08 |
Serinc5 |
serine incorporator 5 |
40061 |
0.15 |
chr5_123000954_123001232 | 4.08 |
Kdm2b |
lysine (K)-specific demethylase 2B |
11270 |
0.09 |
chr3_101939962_101940160 | 4.08 |
Slc22a15 |
solute carrier family 22 (organic anion/cation transporter), member 15 |
15608 |
0.21 |
chr16_52333545_52334027 | 4.08 |
Alcam |
activated leukocyte cell adhesion molecule |
36862 |
0.23 |
chr4_101276012_101276163 | 4.08 |
Gm25124 |
predicted gene, 25124 |
4944 |
0.14 |
chr8_46875705_46875890 | 4.07 |
Gm45481 |
predicted gene 45481 |
41885 |
0.13 |
chr1_193242293_193242617 | 4.07 |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
174 |
0.91 |
chr12_84217495_84217994 | 4.07 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
1137 |
0.3 |
chr1_179561100_179561327 | 4.06 |
Cnst |
consortin, connexin sorting protein |
14704 |
0.15 |
chr2_75781708_75782245 | 4.05 |
Gm13657 |
predicted gene 13657 |
4788 |
0.16 |
chrX_106164142_106164359 | 4.05 |
Gm14856 |
predicted gene 14856 |
12064 |
0.14 |
chr18_63119393_63119593 | 4.05 |
Piezo2 |
piezo-type mechanosensitive ion channel component 2 |
794 |
0.72 |
chr1_154149031_154149342 | 4.04 |
A830008E24Rik |
RIKEN cDNA A830008E24 gene |
31235 |
0.15 |
chr10_95837019_95837195 | 4.03 |
Gm33543 |
predicted gene, 33543 |
5789 |
0.13 |
chr4_149179637_149179837 | 4.03 |
Kif1b |
kinesin family member 1B |
6463 |
0.14 |
chr13_90360078_90360534 | 4.03 |
Gm37708 |
predicted gene, 37708 |
26251 |
0.21 |
chr2_134724278_134724430 | 4.02 |
Gm14037 |
predicted gene 14037 |
6753 |
0.23 |
chr1_95657301_95657591 | 4.02 |
Gm37642 |
predicted gene, 37642 |
8938 |
0.2 |
chr2_166235006_166235175 | 4.01 |
Gm11467 |
predicted gene 11467 |
26463 |
0.14 |
chr18_55409319_55409620 | 4.01 |
Gm37828 |
predicted gene, 37828 |
69957 |
0.12 |
chr7_135704374_135704525 | 4.00 |
Gm45240 |
predicted gene 45240 |
4745 |
0.18 |
chr16_4559726_4560765 | 3.99 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr4_144955934_144956122 | 3.98 |
Gm38074 |
predicted gene, 38074 |
2820 |
0.27 |
chr1_91437622_91437871 | 3.98 |
Per2 |
period circadian clock 2 |
12119 |
0.11 |
chr10_53382724_53383006 | 3.97 |
Cep85l |
centrosomal protein 85-like |
2918 |
0.17 |
chr1_160079452_160079663 | 3.97 |
4930562F07Rik |
RIKEN cDNA 4930562F07 gene |
1572 |
0.34 |
chr6_138139984_138140297 | 3.96 |
Mgst1 |
microsomal glutathione S-transferase 1 |
176 |
0.97 |
chr2_83649030_83649206 | 3.96 |
Zc3h15 |
zinc finger CCCH-type containing 15 |
4495 |
0.24 |
chr12_79557815_79558259 | 3.95 |
Rad51b |
RAD51 paralog B |
230684 |
0.02 |
chr10_96924147_96924298 | 3.95 |
Gm33981 |
predicted gene, 33981 |
34649 |
0.17 |
chr19_55139407_55139583 | 3.95 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
12257 |
0.18 |
chr9_65826224_65827697 | 3.94 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr7_109600775_109601173 | 3.94 |
Denn2b |
DENN domain containing 2B |
1691 |
0.34 |
chr5_123057752_123058346 | 3.93 |
Gm6444 |
predicted gene 6444 |
8193 |
0.09 |
chr11_51832521_51832763 | 3.93 |
Jade2 |
jade family PHD finger 2 |
24483 |
0.15 |
chr9_63006109_63006399 | 3.93 |
Pias1 |
protein inhibitor of activated STAT 1 |
18330 |
0.17 |
chr10_87572581_87572732 | 3.92 |
Pah |
phenylalanine hydroxylase |
25983 |
0.2 |
chr13_24978158_24978317 | 3.91 |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
15610 |
0.13 |
chr4_11147788_11148157 | 3.91 |
Gm11830 |
predicted gene 11830 |
3262 |
0.15 |
chr6_28681956_28682120 | 3.90 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
22871 |
0.21 |
chr3_58234833_58235152 | 3.89 |
Gm26166 |
predicted gene, 26166 |
55365 |
0.11 |
chr17_57230825_57231190 | 3.89 |
C3 |
complement component 3 |
2871 |
0.15 |
chr8_93198242_93198538 | 3.89 |
Ces1d |
carboxylesterase 1D |
552 |
0.68 |
chr11_59423065_59423410 | 3.88 |
Snap47 |
synaptosomal-associated protein, 47 |
24254 |
0.09 |
chr6_31145797_31145976 | 3.88 |
Gm37728 |
predicted gene, 37728 |
1533 |
0.28 |
chr3_57344230_57344525 | 3.87 |
Gm5276 |
predicted gene 5276 |
18011 |
0.19 |
chr16_55816469_55816872 | 3.87 |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
1845 |
0.33 |
chr9_102725851_102726730 | 3.87 |
Amotl2 |
angiomotin-like 2 |
2041 |
0.22 |
chr18_20931394_20931702 | 3.87 |
Rnf125 |
ring finger protein 125 |
13077 |
0.2 |
chr18_54846546_54846732 | 3.86 |
Gm50365 |
predicted gene, 50365 |
8594 |
0.18 |
chr9_109094576_109096217 | 3.86 |
Plxnb1 |
plexin B1 |
7 |
0.95 |
chr3_104279733_104279910 | 3.85 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
59447 |
0.07 |
chr3_38128678_38128843 | 3.84 |
Gm43821 |
predicted gene 43821 |
1431 |
0.43 |
chr4_150785275_150785430 | 3.82 |
Gm13049 |
predicted gene 13049 |
40381 |
0.13 |
chr9_42279817_42280013 | 3.80 |
Gm36435 |
predicted gene, 36435 |
37 |
0.97 |
chr10_63247545_63247832 | 3.80 |
Herc4 |
hect domain and RLD 4 |
1866 |
0.21 |
chr17_24359632_24359953 | 3.79 |
Gm25618 |
predicted gene, 25618 |
2752 |
0.14 |
chr13_97779794_97780130 | 3.78 |
Gm47577 |
predicted gene, 47577 |
10602 |
0.15 |
chr1_39578564_39578720 | 3.77 |
Rnf149 |
ring finger protein 149 |
1237 |
0.32 |
chr4_124752288_124752542 | 3.77 |
Gm12915 |
predicted gene 12915 |
1061 |
0.3 |
chr12_80145470_80145631 | 3.77 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
12706 |
0.12 |
chr13_96742964_96743239 | 3.77 |
Ankrd31 |
ankyrin repeat domain 31 |
5171 |
0.2 |
chr18_8719331_8720018 | 3.75 |
Gm26119 |
predicted gene, 26119 |
21318 |
0.19 |
chr10_120015280_120015431 | 3.74 |
Grip1 |
glutamate receptor interacting protein 1 |
22249 |
0.22 |
chr1_179046490_179046687 | 3.74 |
Smyd3 |
SET and MYND domain containing 3 |
57243 |
0.16 |
chr11_30648868_30649937 | 3.74 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr1_162891926_162892449 | 3.74 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr1_39425558_39425731 | 3.73 |
Gm37265 |
predicted gene, 37265 |
5712 |
0.18 |
chr15_55043133_55043358 | 3.73 |
Taf2 |
TATA-box binding protein associated factor 2 |
2921 |
0.22 |
chr17_70850487_70852089 | 3.72 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr3_38151941_38152092 | 3.72 |
Gm43821 |
predicted gene 43821 |
21825 |
0.17 |
chr7_130839379_130839651 | 3.72 |
Plekha1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
26241 |
0.13 |
chr3_101958182_101958338 | 3.72 |
Slc22a15 |
solute carrier family 22 (organic anion/cation transporter), member 15 |
33807 |
0.16 |
chr17_49368958_49369190 | 3.72 |
Gm18067 |
predicted gene, 18067 |
37578 |
0.14 |
chr4_63553863_63554097 | 3.71 |
Tmem268 |
transmembrane protein 268 |
4801 |
0.13 |
chr1_140183199_140183575 | 3.70 |
Cfh |
complement component factor h |
24 |
0.98 |
chr5_90460654_90460971 | 3.70 |
Alb |
albumin |
85 |
0.97 |
chr12_79372810_79372961 | 3.69 |
Rad51b |
RAD51 paralog B |
45532 |
0.15 |
chr6_146907857_146908129 | 3.68 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
19404 |
0.14 |
chr7_131256975_131257257 | 3.68 |
Cdcp3 |
CUB domain containing protein 3 |
46863 |
0.09 |
chr8_11062439_11062618 | 3.68 |
B830042I05Rik |
RIKEN cDNA B830042I05 gene |
8518 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 4.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.9 | 11.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.0 | 8.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.8 | 11.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.5 | 2.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
2.4 | 7.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.2 | 8.8 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.1 | 6.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.0 | 12.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.0 | 6.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.0 | 5.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.9 | 7.8 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.9 | 9.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.9 | 15.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
1.9 | 5.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.8 | 5.5 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.8 | 5.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.8 | 5.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.8 | 5.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.8 | 1.8 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
1.8 | 5.3 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.7 | 5.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.7 | 8.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.6 | 8.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.6 | 3.3 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.6 | 6.5 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
1.6 | 11.2 | GO:0060613 | fat pad development(GO:0060613) |
1.5 | 6.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.5 | 4.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.5 | 1.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.5 | 6.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
1.4 | 4.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.4 | 4.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.4 | 5.6 | GO:0010958 | regulation of amino acid import(GO:0010958) |
1.4 | 4.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.4 | 5.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.4 | 4.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.4 | 5.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.4 | 1.4 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
1.4 | 2.7 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.4 | 6.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.3 | 1.3 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
1.3 | 1.3 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.3 | 5.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.3 | 5.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.3 | 6.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.2 | 3.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.2 | 2.5 | GO:0019627 | urea metabolic process(GO:0019627) |
1.2 | 3.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.2 | 4.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.2 | 4.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.2 | 3.6 | GO:0032782 | bile acid secretion(GO:0032782) |
1.2 | 4.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.2 | 2.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.2 | 3.6 | GO:0036394 | amylase secretion(GO:0036394) |
1.2 | 3.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 8.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.1 | 3.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.1 | 3.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.1 | 5.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 4.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.1 | 2.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.1 | 4.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.1 | 6.8 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.1 | 5.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.1 | 3.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.1 | 2.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.1 | 4.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.1 | 3.2 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.1 | 4.3 | GO:0009597 | detection of virus(GO:0009597) |
1.1 | 4.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 1.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.1 | 2.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.1 | 3.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.0 | 3.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.0 | 2.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.0 | 2.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.0 | 4.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.0 | 2.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.0 | 4.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
1.0 | 8.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.0 | 9.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.0 | 5.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.0 | 3.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.0 | 1.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.0 | 3.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.0 | 4.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.0 | 3.9 | GO:0019532 | oxalate transport(GO:0019532) |
1.0 | 1.0 | GO:0001705 | ectoderm formation(GO:0001705) |
1.0 | 1.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.0 | 2.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.0 | 1.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.9 | 2.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.9 | 2.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.9 | 5.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.9 | 1.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.9 | 2.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.9 | 3.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 2.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.9 | 2.8 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.9 | 1.8 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.9 | 3.6 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 4.5 | GO:0015825 | L-serine transport(GO:0015825) |
0.9 | 2.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.9 | 1.8 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.9 | 3.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.9 | 3.6 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.9 | 1.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.9 | 0.9 | GO:1901656 | glycoside transport(GO:1901656) |
0.9 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.9 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.9 | 5.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.9 | 2.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.9 | 1.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.9 | 2.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.8 | 2.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.8 | 0.8 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.8 | 8.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.8 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.8 | 2.5 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 1.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 1.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.8 | 1.7 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.8 | 3.3 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.8 | 5.0 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 4.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.8 | 2.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.8 | 3.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.8 | 2.5 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.8 | 1.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 3.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.8 | 4.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.8 | 0.8 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.8 | 2.5 | GO:0003166 | bundle of His development(GO:0003166) |
0.8 | 3.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.8 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 4.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.8 | 0.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.8 | 9.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.8 | 1.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.8 | 2.4 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.8 | 4.8 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 2.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 5.6 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.8 | 0.8 | GO:0033483 | gas homeostasis(GO:0033483) |
0.8 | 1.6 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.8 | 1.6 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.8 | 10.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.8 | 1.6 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.8 | 7.8 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 4.7 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.8 | 4.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.8 | 3.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.8 | 1.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 2.3 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.8 | 0.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 3.0 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.7 | 2.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 3.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 2.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 3.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.7 | 3.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.7 | 3.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.7 | 5.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.7 | 2.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 4.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.7 | 5.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.7 | 1.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 2.2 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 2.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 0.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.7 | 4.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 2.9 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.7 | 2.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.7 | 2.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.7 | 2.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.7 | 0.7 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 0.7 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.7 | 0.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.7 | 3.4 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.7 | 0.7 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.7 | 0.7 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.7 | 2.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 0.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.7 | 2.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 2.7 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.7 | 4.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.7 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.7 | 2.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.7 | 4.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 2.0 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.7 | 2.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.7 | 0.7 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.7 | 5.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 2.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.7 | 2.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 2.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 2.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.7 | 2.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.7 | 1.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.7 | 1.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.7 | 2.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 3.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 2.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 2.0 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.7 | 2.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.7 | 3.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.7 | 2.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.7 | 3.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.7 | 2.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 3.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 0.7 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.7 | 3.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.7 | 2.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 7.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 0.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.6 | 2.6 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.6 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 12.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.6 | 5.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.6 | 0.6 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.6 | 3.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.6 | 1.9 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.6 | 1.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.6 | 3.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.6 | 2.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 2.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.6 | 1.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 3.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.6 | 2.5 | GO:0046909 | intermembrane transport(GO:0046909) |
0.6 | 1.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.6 | 0.6 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 2.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.6 | 3.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 1.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.6 | 8.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 1.9 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.6 | 1.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.6 | 4.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.6 | 1.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 4.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.6 | 6.1 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.6 | 5.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.6 | 3.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.6 | 3.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 1.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.6 | 1.8 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
0.6 | 1.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 0.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 1.2 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 1.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.6 | 2.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.6 | 3.0 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 3.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 2.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.6 | 1.2 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.6 | 1.8 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.6 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.6 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.6 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.6 | 1.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.6 | 4.7 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 2.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.6 | 2.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.6 | 0.6 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.6 | 4.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.6 | 7.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 4.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 1.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 1.8 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.6 | 0.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.6 | 1.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.6 | 2.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 1.8 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 1.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 2.3 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 2.9 | GO:0032328 | alanine transport(GO:0032328) |
0.6 | 5.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 1.2 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 7.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.6 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 2.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 1.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 4.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 5.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 1.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 2.3 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.6 | 2.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.6 | 2.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.6 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.6 | 1.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 2.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 0.6 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.6 | 2.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.6 | 2.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 4.4 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.6 | 0.6 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.5 | 1.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.5 | 1.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 1.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.5 | 1.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 2.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.5 | 1.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 3.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 3.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 4.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 0.5 | GO:0060842 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.5 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 2.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.5 | 5.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 2.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 1.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.5 | 1.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 1.6 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 4.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 0.5 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.5 | 2.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 2.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 1.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 1.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 0.5 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.5 | 2.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 1.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.5 | 2.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 2.1 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.5 | 1.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 0.5 | GO:2000118 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 2.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.5 | 2.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 8.2 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.5 | 1.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.5 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 3.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.5 | 1.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 1.5 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.5 | 2.0 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.5 | 2.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 2.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.5 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 2.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 1.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 0.5 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.5 | 0.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.5 | 2.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.0 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 1.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.5 | 1.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 1.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 12.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.5 | 4.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.5 | 12.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.5 | 1.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.5 | 2.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 2.0 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 1.0 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 1.0 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.5 | 11.3 | GO:0014823 | response to activity(GO:0014823) |
0.5 | 1.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.5 | 3.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.5 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 2.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 3.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 1.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.5 | 0.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 2.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 1.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 2.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 4.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 3.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.5 | 4.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 3.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.5 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 3.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 2.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.5 | 1.0 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 1.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 1.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 8.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 2.8 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.5 | 4.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.5 | 1.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 0.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.5 | 0.9 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 1.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.5 | 0.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.5 | 3.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.5 | 3.7 | GO:0042730 | fibrinolysis(GO:0042730) |
0.5 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.5 | 2.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.5 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.5 | 2.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 0.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 9.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 1.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 0.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.5 | 1.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.5 | 1.4 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 1.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.5 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 3.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 1.8 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 0.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 0.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 0.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.5 | 0.5 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 1.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 4.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 0.9 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.4 | 0.9 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 1.8 | GO:0009838 | abscission(GO:0009838) |
0.4 | 0.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.4 | 1.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 3.6 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 9.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 0.9 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.4 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 1.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.4 | 7.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.4 | 2.7 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 3.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 0.4 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.4 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 1.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 3.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 0.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.4 | 2.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 3.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 7.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 2.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 3.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 1.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.7 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.4 | 3.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.9 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.4 | 1.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.4 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.4 | 1.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 0.4 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.4 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 0.4 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.4 | 3.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.4 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 2.1 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 1.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 2.5 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 1.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.4 | 8.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 1.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 2.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.4 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.4 | 1.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 2.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.4 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 2.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.4 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.4 | 0.8 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) |
0.4 | 0.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.2 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.4 | 1.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 2.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.4 | 1.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.4 | 1.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 3.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 3.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 5.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.4 | 1.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.4 | 2.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.4 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 10.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 3.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 4.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 2.3 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 3.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 1.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.4 | 2.3 | GO:0007343 | egg activation(GO:0007343) |
0.4 | 1.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 1.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 1.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.4 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.9 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 3.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.4 | 1.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 2.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 1.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 2.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 6.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.4 | 1.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 1.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 0.7 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.4 | 0.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.4 | 5.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 1.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 0.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.4 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 0.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.4 | 3.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 0.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 0.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.4 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 2.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 0.7 | GO:0060416 | response to growth hormone(GO:0060416) |
0.4 | 1.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 2.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 1.5 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 8.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 2.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 1.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.4 | 4.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.4 | 0.7 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 2.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.4 | 1.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 2.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 1.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 1.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.4 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.4 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 0.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.4 | 1.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 6.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 1.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.4 | 0.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 5.4 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.4 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 0.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 1.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 3.9 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.4 | 0.4 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.4 | 2.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.4 | 2.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 5.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.4 | 1.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.4 | 9.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.4 | 1.4 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.4 | 8.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.4 | 14.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.4 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.4 | 2.5 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.4 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 2.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.3 | 1.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 4.9 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.3 | 2.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 2.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 3.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 | 1.4 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.3 | 1.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) |
0.3 | 1.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 1.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 0.3 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.3 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.3 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 2.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 2.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 0.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 1.0 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.3 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 1.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 1.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 3.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 3.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 1.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.3 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.3 | 0.7 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 2.9 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 1.0 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.3 | 2.6 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.3 | 0.7 | GO:0070268 | cornification(GO:0070268) |
0.3 | 2.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 1.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.6 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.3 | 4.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 2.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.3 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.3 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 2.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.3 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 2.6 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 1.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.3 | 0.6 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.3 | 1.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.3 | GO:0061316 | canonical Wnt signaling pathway involved in heart development(GO:0061316) |
0.3 | 4.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 1.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.9 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.9 | GO:0044838 | cell quiescence(GO:0044838) |
0.3 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 1.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 10.0 | GO:0006956 | complement activation(GO:0006956) |
0.3 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 1.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 1.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 2.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.3 | 0.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.3 | 0.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 0.3 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.3 | 1.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 1.8 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.3 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.9 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.3 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 1.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 1.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 0.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.6 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 1.2 | GO:0007567 | parturition(GO:0007567) |
0.3 | 1.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.3 | 0.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.3 | 5.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.9 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.3 | 0.6 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 2.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 12.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 0.9 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.2 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 0.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.3 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.3 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.3 | 2.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.6 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 1.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 1.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 0.3 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 0.3 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 4.1 | GO:0019915 | lipid storage(GO:0019915) |
0.3 | 0.6 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.3 | 0.9 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.3 | 2.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 7.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.2 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.3 | 2.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.3 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 1.7 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.3 | 3.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 0.6 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.6 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 0.6 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.3 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 1.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 0.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.3 | 1.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.3 | 2.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.3 | GO:0033084 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) |
0.3 | 1.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.3 | GO:0043379 | regulation of mast cell cytokine production(GO:0032763) memory T cell differentiation(GO:0043379) |
0.3 | 0.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 1.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 7.5 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 1.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 0.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.3 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 0.5 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 1.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 0.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.3 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 0.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 2.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.3 | 2.2 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 5.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.1 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 3.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.3 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 1.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 3.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.3 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.5 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 2.1 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 2.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 1.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.3 | 2.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 0.3 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.3 | 1.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 5.4 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.3 | 2.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 5.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.3 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.3 | 0.5 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.5 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.3 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 3.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.5 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 2.6 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.3 | 1.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.5 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 2.8 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
0.3 | 0.5 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 2.3 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.3 | 3.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.5 | GO:0045010 | actin nucleation(GO:0045010) |
0.3 | 0.8 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 0.8 | GO:0015893 | drug transport(GO:0015893) |
0.3 | 0.3 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.2 | 1.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.2 | GO:0006312 | mitotic recombination(GO:0006312) |
0.2 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 1.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.2 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 1.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.2 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 2.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 3.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 3.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.2 | 1.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 0.2 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.2 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.4 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.2 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 1.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 1.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.7 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 2.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.2 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 2.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 1.0 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.7 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 1.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 2.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.2 | 0.5 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.2 | 0.7 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 3.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.9 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 2.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 1.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.5 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.2 | 3.5 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 2.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.2 | 1.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 2.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 0.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.2 | 0.5 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 1.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 1.8 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 2.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 13.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.7 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.2 | 0.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.7 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 2.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 1.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.2 | 1.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.7 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 1.8 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.9 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 2.9 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.7 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.8 | GO:0033273 | response to vitamin(GO:0033273) |
0.2 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 13.8 | GO:0006457 | protein folding(GO:0006457) |
0.2 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 7.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.2 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 5.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 2.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.3 | GO:0051875 | pigment granule localization(GO:0051875) |
0.2 | 0.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 0.4 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 3.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.2 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 1.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.8 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.2 | GO:0034369 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.2 | 1.7 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 2.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 1.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.4 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 5.2 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.2 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 0.6 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 1.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.6 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.2 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.2 | 0.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 2.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 1.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.6 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.2 | 1.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 1.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 1.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 1.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.8 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 1.6 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 1.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.2 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 3.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.8 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.6 | GO:0033387 | putrescine biosynthetic process(GO:0009446) putrescine biosynthetic process from ornithine(GO:0033387) |
0.2 | 1.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 1.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 1.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.4 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 3.7 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 2.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.4 | GO:0010324 | membrane invagination(GO:0010324) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 1.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 2.9 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 2.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.2 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 1.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 1.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 1.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 1.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 2.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 3.7 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 0.7 | GO:0034440 | lipid oxidation(GO:0034440) |
0.2 | 0.6 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.6 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.2 | 5.2 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.2 | GO:0007127 | meiosis I(GO:0007127) |
0.2 | 0.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 0.2 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 1.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 1.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.2 | GO:0033079 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.2 | 0.4 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.2 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
0.2 | 0.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.2 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 1.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.2 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 2.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 1.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.7 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 1.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 0.5 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 1.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 1.9 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.2 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.3 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.2 | 0.5 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.2 | 0.8 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.2 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 1.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.3 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 0.3 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 1.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 4.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 1.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.2 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell development(GO:0060926) |
0.2 | 0.8 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.5 | GO:0043039 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.2 | 1.6 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 1.3 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.3 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.3 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 1.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 2.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.2 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.3 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 2.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.2 | 1.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 2.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.9 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.2 | 0.9 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 2.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 1.5 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.2 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.2 | GO:0032633 | interleukin-4 production(GO:0032633) |
0.2 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 2.8 | GO:0035036 | cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
0.2 | 0.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 1.7 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 1.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 1.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 3.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 5.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.2 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 1.4 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.2 | 0.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 8.1 | GO:0010876 | lipid localization(GO:0010876) |
0.1 | 1.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 1.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.4 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.1 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 1.5 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 2.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 6.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 1.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.6 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 2.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 2.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 5.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 3.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 2.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 7.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 2.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.8 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.1 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.1 | 0.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.8 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 1.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.3 | GO:0043299 | leukocyte degranulation(GO:0043299) |
0.1 | 8.1 | GO:0007599 | hemostasis(GO:0007599) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.7 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.8 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.5 | GO:0006650 | glycerophospholipid metabolic process(GO:0006650) |
0.1 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.4 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 1.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.1 | 0.5 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 1.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 8.5 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 6.7 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.1 | 0.1 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.6 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.4 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 3.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0046386 | deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.5 | GO:0051324 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.7 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.2 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 2.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 2.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 1.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.7 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 1.9 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 3.2 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.2 | GO:0061437 | renal system vasculature development(GO:0061437) kidney vasculature development(GO:0061440) glomerulus vasculature development(GO:0072012) |
0.1 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.2 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 4.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 2.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.1 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.9 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 2.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.2 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 1.1 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 2.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 1.2 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.1 | 1.4 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 1.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.4 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.7 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.9 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 8.6 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.7 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.2 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.1 | GO:1900747 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.7 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 0.2 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:0009310 | amine catabolic process(GO:0009310) |
0.1 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.9 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.1 | 1.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.1 | GO:0097531 | mast cell migration(GO:0097531) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.5 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.3 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.4 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.5 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.5 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 10.2 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 6.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
0.1 | 0.1 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 2.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.2 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 1.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.4 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 2.5 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 1.5 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
0.1 | 0.7 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) |
0.1 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.5 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.6 | GO:0031960 | response to corticosteroid(GO:0031960) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) negative regulation of striated muscle cell differentiation(GO:0051154) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0002275 | myeloid cell activation involved in immune response(GO:0002275) |
0.0 | 1.1 | GO:0003281 | ventricular septum development(GO:0003281) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.0 | 0.0 | GO:0002248 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.2 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.0 | 0.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 2.2 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.5 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.0 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 1.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.0 | 0.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.0 | 0.0 | GO:0019076 | viral release from host cell(GO:0019076) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.8 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 4.0 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.0 | 0.1 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
0.0 | 0.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.1 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 2.0 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.0 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.0 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.0 | GO:0060193 | positive regulation of lipase activity(GO:0060193) |
0.0 | 0.0 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 10.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.9 | 5.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.8 | 10.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.5 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
1.5 | 5.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.2 | 4.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 9.0 | GO:0042627 | chylomicron(GO:0042627) |
1.1 | 5.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.0 | 3.1 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 3.0 | GO:0031523 | Myb complex(GO:0031523) |
1.0 | 3.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.0 | 4.0 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 23.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 1.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.9 | 2.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.9 | 3.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 4.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.9 | 2.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 3.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 1.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 2.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.8 | 2.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 9.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.7 | 3.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 5.1 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 7.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 4.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 2.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 3.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 2.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 2.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.7 | 11.4 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.7 | 1.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 3.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.7 | 5.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 31.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.6 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 4.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 6.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.6 | 57.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 2.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 1.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 4.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 2.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 2.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 5.9 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 1.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.6 | 3.5 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.6 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 2.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.6 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.6 | 0.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 2.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 0.6 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 0.6 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.6 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 2.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 5.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 1.7 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.5 | 1.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 2.2 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 2.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 3.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 6.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.5 | 2.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 1.1 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 2.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.5 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.5 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.5 | 6.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 2.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 2.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.5 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 1.5 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 4.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.5 | 2.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 2.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 1.0 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.5 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 10.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 25.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 28.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 1.9 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 8.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 1.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 7.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 1.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.4 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.4 | 5.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 11.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.4 | 1.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 2.6 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 4.7 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 3.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 5.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 0.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.4 | 28.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 1.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 2.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 4.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 1.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 12.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 3.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 2.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 2.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 0.4 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 1.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.4 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 35.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 8.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 2.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 7.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 3.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 10.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 2.2 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 4.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 4.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 1.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 8.5 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 4.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.4 | 1.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 19.9 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 3.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 4.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.3 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 5.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 10.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.7 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 5.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 12.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.3 | 4.3 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 3.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 2.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 8.8 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 2.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 10.6 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 1.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 6.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.3 | 5.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 0.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 4.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 2.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 0.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 2.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 0.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 2.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 3.4 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 3.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 3.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 2.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 14.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 4.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.3 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 1.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 1.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.0 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 2.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.1 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 11.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 11.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.3 | 1.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 2.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.8 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 6.6 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 1.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 4.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 2.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 2.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.4 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 2.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.3 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 6.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 0.8 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.3 | 2.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.3 | 28.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 1.0 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 1.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 1.5 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 11.2 | GO:0016605 | PML body(GO:0016605) |
0.3 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 2.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 3.0 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 2.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 6.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.2 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 2.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 0.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 20.0 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 2.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.6 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 13.9 | GO:0030496 | midbody(GO:0030496) |
0.2 | 54.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 2.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 8.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 6.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 2.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 1.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 3.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 1.3 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 2.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 7.0 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.6 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 3.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 2.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 3.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 25.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 13.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 59.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 14.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 2.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 4.1 | GO:0030286 | dynein complex(GO:0030286) |
0.2 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 3.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 5.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 23.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.2 | 0.6 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 3.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 3.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 8.8 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 297.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.1 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.9 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 5.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 27.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 5.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.2 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 143.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.8 | GO:0002102 | podosome(GO:0002102) |
0.2 | 115.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 4.5 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 4.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.8 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.1 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 13.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 6.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 2.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.5 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 14.6 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.7 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 4.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 3.5 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 18.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 55.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 31.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 1.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 21.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 1.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.3 | 6.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.3 | 6.8 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.2 | 6.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.1 | 6.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.1 | 8.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.9 | 7.4 | GO:0035276 | ethanol binding(GO:0035276) |
1.8 | 7.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.7 | 7.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.6 | 10.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.5 | 4.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.5 | 4.5 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.4 | 10.1 | GO:0018631 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
1.4 | 4.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.4 | 5.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 4.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.4 | 4.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.3 | 8.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.3 | 5.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.3 | 7.7 | GO:0008199 | ferric iron binding(GO:0008199) |
1.3 | 8.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.3 | 1.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.3 | 3.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.2 | 3.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.2 | 19.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.2 | 3.7 | GO:0004096 | catalase activity(GO:0004096) |
1.2 | 3.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 3.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 4.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.2 | 3.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.2 | 1.2 | GO:0002054 | nucleobase binding(GO:0002054) |
1.1 | 3.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.1 | 2.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.1 | 3.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.1 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.1 | 3.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.1 | 3.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.1 | 5.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.1 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
1.1 | 1.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.0 | 2.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 3.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.0 | 6.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 3.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 3.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.0 | 3.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 3.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.0 | 3.9 | GO:0045340 | mercury ion binding(GO:0045340) |
1.0 | 7.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.0 | 2.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.9 | 3.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 2.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.9 | 3.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.9 | 2.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 2.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.9 | 3.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.9 | 2.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 2.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.9 | 2.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.9 | 4.4 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 2.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.9 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.9 | 4.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.9 | 1.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.9 | 2.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.9 | 3.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.9 | 4.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.9 | 1.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 2.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.8 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 2.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.8 | 9.9 | GO:0001846 | opsonin binding(GO:0001846) |
0.8 | 4.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 2.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 1.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.8 | 14.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 2.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 4.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.8 | 3.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 3.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.8 | 3.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 6.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 14.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 3.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.8 | 3.8 | GO:0035671 | enone reductase activity(GO:0035671) |
0.8 | 2.3 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 2.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.7 | 3.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 3.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 4.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 2.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.7 | 3.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.7 | 2.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.7 | 2.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 5.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 2.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.7 | 4.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.8 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 1.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 5.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 7.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.7 | 4.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.7 | 2.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.7 | 2.0 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.7 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.7 | 4.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.7 | 6.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 8.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 2.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.7 | 7.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 7.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 3.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 1.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 5.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.6 | 3.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 2.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.9 | GO:0070061 | fructose binding(GO:0070061) |
0.6 | 2.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.6 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 1.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 1.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 1.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 1.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 0.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.6 | 4.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 2.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.6 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 2.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 2.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 0.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.6 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.6 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 2.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.6 | 1.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 2.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 3.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 4.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 2.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.6 | 2.3 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.6 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 13.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 4.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.6 | 4.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.6 | 1.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.6 | 1.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.6 | 3.9 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.6 | 2.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 3.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 6.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 2.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 2.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 5.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.6 | 3.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 1.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 1.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 2.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.5 | 3.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 1.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 1.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 2.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.5 | 6.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.5 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
0.5 | 5.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 2.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 3.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.5 | 1.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 3.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 1.6 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 2.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 2.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 4.8 | GO:0019841 | retinol binding(GO:0019841) |
0.5 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 3.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 6.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 2.6 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 5.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 2.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 5.7 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 0.5 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 14.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 15.5 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.5 | 6.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 3.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 2.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 1.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 1.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 4.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 4.3 | GO:0001848 | complement binding(GO:0001848) |
0.5 | 0.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.5 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 3.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.5 | 1.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 4.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 1.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 5.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 5.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 2.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 3.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.5 | 1.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.5 | 1.8 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 1.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.5 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.5 | 1.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.5 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 13.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 8.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.5 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 4.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 7.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 4.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.3 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 1.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.4 | 1.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 2.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 0.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.4 | 0.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 1.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 12.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 4.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 4.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.4 | 13.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 1.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 7.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 8.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 1.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 3.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 2.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 1.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.4 | 1.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 2.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 1.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 1.3 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 4.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.4 | 8.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 12.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.4 | 2.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 2.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.4 | 1.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 5.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 5.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 3.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.4 | 13.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.4 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 4.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 1.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 5.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.4 | 2.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 2.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 2.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 3.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 2.7 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 1.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 2.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 5.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 1.5 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 2.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 8.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 2.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 2.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 0.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 1.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.8 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 3.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 12.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.4 | 4.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 7.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 3.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 2.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 6.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 1.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 1.1 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 7.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.4 | 2.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 2.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 2.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 3.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 4.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 0.7 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.4 | 1.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 3.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 1.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 0.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.4 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.4 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 3.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.3 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 2.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.3 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 25.2 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.3 | 16.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 4.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.7 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 9.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 3.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 5.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 1.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 2.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 3.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.3 | 0.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 0.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 4.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.3 | 0.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 12.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 4.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 5.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 2.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 6.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 0.9 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 4.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 4.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 28.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 1.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 1.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 6.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 0.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 1.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 3.3 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 6.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 3.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 3.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 2.0 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 5.2 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 2.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 0.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.3 | 1.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 4.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.3 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.3 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.3 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 4.9 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 1.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 1.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 6.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 2.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 1.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 1.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 5.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 4.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 7.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
0.3 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 2.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 4.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 1.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 6.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.3 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 3.9 | GO:0050661 | NADP binding(GO:0050661) |
0.3 | 2.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 2.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 3.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 1.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 2.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 4.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 1.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 8.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 1.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 1.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 6.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 3.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 2.2 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 2.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 1.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 5.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 2.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 2.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 4.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.9 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 2.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 1.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 2.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 2.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.9 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.2 | 1.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.2 | 0.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.2 | 4.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 0.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 2.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 37.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 9.0 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 24.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 14.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.6 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 1.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 3.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 7.3 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 3.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 7.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 4.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 3.0 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 3.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.6 | GO:0001162 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 1.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.7 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 4.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 5.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 30.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 4.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 4.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 2.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.9 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 9.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 3.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 2.9 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.2 | 1.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 3.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 5.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 12.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.3 | GO:0016894 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 3.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 7.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 4.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.2 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 1.6 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 2.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 4.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 25.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 5.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.2 | 1.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 8.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.7 | GO:0009975 | cyclase activity(GO:0009975) |
0.2 | 0.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.0 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 1.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 8.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 2.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 4.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.6 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 4.1 | GO:0008907 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 3.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 8.8 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 1.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 4.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 3.2 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.9 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 3.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 5.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 1.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 3.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 6.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 2.6 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 3.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 3.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 7.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 20.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 3.7 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 8.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 4.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 19.0 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.8 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 5.0 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 7.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 3.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 1.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.1 | GO:0071813 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.5 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.1 | 2.1 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 1.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 1.3 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.7 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 3.0 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 32.5 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 4.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 3.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 2.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.5 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.7 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.0 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.4 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 1.8 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 1.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 2.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.4 | 4.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.1 | 3.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 22.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.8 | 33.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 4.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.7 | 4.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 21.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 20.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.6 | 1.9 | ST STAT3 PATHWAY | STAT3 Pathway |
0.6 | 8.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 0.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 5.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 12.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 8.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 3.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 11.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 5.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 25.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 8.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 4.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 4.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 2.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 8.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 5.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 16.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 16.2 | PID FOXO PATHWAY | FoxO family signaling |
0.5 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 9.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 8.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 3.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 3.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 7.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 1.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 6.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 3.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 4.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 1.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 4.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 6.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 9.1 | PID ATM PATHWAY | ATM pathway |
0.4 | 3.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 3.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 4.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 9.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 6.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 3.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 10.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 2.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 9.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 4.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 14.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 10.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 6.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 9.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 4.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 8.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 6.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 2.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 5.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 12.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 2.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 4.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 6.5 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 4.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 9.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 3.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 4.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 3.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 14.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 7.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 4.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 3.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 5.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 38.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 7.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 1.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.5 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 3.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 1.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 5.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 15.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.3 | 12.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 17.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.2 | 10.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.1 | 3.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.1 | 15.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.0 | 11.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.0 | 13.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 5.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 24.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.9 | 19.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.8 | 7.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.8 | 10.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 9.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 7.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 18.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 11.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.7 | 12.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 7.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 10.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 6.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 12.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.6 | 1.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 6.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 17.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.6 | 3.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.6 | 8.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 15.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 14.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.6 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 1.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 0.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.6 | 3.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 1.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 8.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 7.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.6 | 16.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 2.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 6.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 6.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 1.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.5 | 24.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 23.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.5 | 5.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 2.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 7.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 2.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 3.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.5 | 5.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 5.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 6.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 7.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 13.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 3.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 15.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 5.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 7.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 2.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.5 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 6.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 9.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 5.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.4 | 14.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 6.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 11.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 7.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 3.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 1.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 7.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 4.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 1.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 4.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 5.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 3.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 4.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.4 | 2.0 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.4 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 2.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 6.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 5.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.4 | 4.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 3.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 4.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 26.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 2.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 6.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.4 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.4 | 3.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 45.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 2.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 2.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 3.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 4.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 21.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.8 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 10.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 0.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 5.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 3.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 3.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.3 | 2.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 4.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 0.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 7.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 3.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 1.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 0.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 2.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 2.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 4.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 6.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 0.9 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 0.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 2.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 8.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.3 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 0.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 2.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 7.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 3.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.3 | 2.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 8.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 6.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 1.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 11.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 3.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 3.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 9.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 2.1 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 6.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 8.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 1.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 7.0 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.3 | 6.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 1.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 1.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 7.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 1.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 15.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 5.0 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 5.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 1.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 8.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 0.9 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 2.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 17.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 4.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 7.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 5.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 0.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 5.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.5 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 7.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 4.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 5.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 1.2 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.2 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.3 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 5.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.2 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 12.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.7 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 5.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.4 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 12.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.6 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 5.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 1.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 1.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.2 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |